The interpretation of NGAL levels in CKD is complex and requires consideration of various factors, including the underlying etiology of kidney disease, the stage of CKD, the presence of comorbidities, and the clinical context of the individual patient. This evidence concerns the gene LCN2 and chronic kidney disease.